Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Plaque burden can be assessed using intravascular optical coherence tomography and a dedicated automated processing algorithm: a comparison study with intravascular ultrasound.

Gerbaud E, Weisz G, Tanaka A, Luu R, Osman HASH, Baldwin G, Coste P, Cognet L, Waxman S, Zheng H, Moses JW, Mintz GS, Akasaka T, Maehara A, Tearney GJ.

Eur Heart J Cardiovasc Imaging. 2019 Jul 21. pii: jez185. doi: 10.1093/ehjci/jez185. [Epub ahead of print]

PMID:
31326995
2.

Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome.

Gerbaud E, Darier R, Montaudon M, Beauvieux MC, Coffin-Boutreux C, Coste P, Douard H, Ouattara A, Catargi B.

Diabetes Care. 2019 Apr;42(4):674-681. doi: 10.2337/dc18-2047. Epub 2019 Feb 6.

PMID:
30728222
3.

One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.

Danchin N, Puymirat E, Cayla G, Cottin Y, Coste P, Gilard M, Goldstein P, Braun F, Belle L, Montalescot G, Ferrières J, Schiele F, Simon T; FAST-MI Investigators.

Circ Cardiovasc Interv. 2018 Sep;11(9):e007241. doi: 10.1161/CIRCINTERVENTIONS.118.007241.

PMID:
30354592
4.

Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH).

Calleja JL, Macias J, Forns X, Garcia F, Berenguer M, Garcia Deltoro M, Buti M, Granados R, Carrion JA, Morano L, Fernandez I, Coste P, Pineda JA.

Gastroenterol Hepatol. 2018 Nov;41(9):597-608. doi: 10.1016/j.gastrohep.2018.07.010. Epub 2018 Sep 27. English, Spanish. No abstract available.

PMID:
30270150
5.

Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention.

Fiore M, Gerbaud E, Coste P, Cetran L, Marchand H, Seguy B.

Resuscitation. 2018 Sep;130:e1-e2. doi: 10.1016/j.resuscitation.2018.06.032. Epub 2018 Jun 30. No abstract available.

PMID:
29969644
6.

Early clinical outcomes as a function of use of newer oral P2Y12 inhibitors versus clopidogrel in the EUROMAX trial.

Huber K, Ducrocq G, Hamm CW, van 't Hof A, Lapostolle F, Coste P, Gordini G, Steinmetz J, Verheugt FWA, Adgey J, Nibbe L, Kaniĉ V, Clemmensen P, Zeymer U, Bernstein D, Prats J, Deliargyris EN, Gabriel Steg P.

Open Heart. 2017 Nov 28;4(2):e000677. doi: 10.1136/openhrt-2017-000677. eCollection 2017.

7.

Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction - Relationship With Infarct Size, Adverse Remodeling, and Events at 1 Year.

Cuenin L, Lamoureux S, Schaaf M, Bochaton T, Monassier JP, Claeys MJ, Rioufol G, Finet G, Garcia-Dorado D, Angoulvant D, Elbaz M, Delarche N, Coste P, Metge M, Perret T, Motreff P, Bonnefoy-Cudraz E, Vanzetto G, Morel O, Boussaha I, Ovize M, Mewton N.

Circ J. 2018 Apr 25;82(5):1379-1386. doi: 10.1253/circj.CJ-17-0671. Epub 2017 Sep 23.

8.

Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.

Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, Lemesle G, Motreff P, Popovic B, Khalife K, Labèque JN, Perret T, Le Ray C, Orion L, Jouve B, Blanchard D, Peycher P, Silvain J, Steg PG, Goldstein P, Guéret P, Belle L, Aissaoui N, Ferrières J, Schiele F, Danchin N; USIK, USIC 2000, and FAST-MI investigators.

Circulation. 2017 Nov 14;136(20):1908-1919. doi: 10.1161/CIRCULATIONAHA.117.030798. Epub 2017 Aug 27.

PMID:
28844989
9.

French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data.

Belle L, Cayla G, Cottin Y, Coste P, Khalife K, Labèque JN, Farah B, Perret T, Goldstein P, Gueugniaud PY, Braun F, Gauthier J, Gilard M, Le Heuzey JY, Naccache N, Drouet E, Bataille V, Ferrières J, Puymirat E, Schiele F, Simon T, Danchin N; FAST-MI 2015 investigators.

Arch Cardiovasc Dis. 2017 Jun - Jul;110(6-7):366-378. doi: 10.1016/j.acvd.2017.05.001. Epub 2017 Jun 21.

10.

Long-Term Clinical Outcomes According to Previous Manifestations of Atherosclerotic Disease (from the FAST-MI 2010 Registry).

Puymirat E, Aissaoui N, Lemesle G, Cottin Y, Coste P, Schiele F, Ferrières J, Simon T, Danchin N; FAST-MI Investigators.

Am J Cardiol. 2017 Mar 1;119(5):692-697. doi: 10.1016/j.amjcard.2016.11.032. Epub 2016 Dec 2.

PMID:
28038725
11.

Minimalist immediate mechanical intervention approach in the management of an acute proximal left anterior descending artery occlusion with extensive thrombus burden in the left main coronary artery.

Cetran L, Casassus F, Tearney GJ, Seguy B, Poustis P, Coste P, Gerbaud E.

Minerva Cardioangiol. 2017 Feb;65(1):102-105. doi: 10.23736/S0026-4725.16.04204-3. No abstract available.

PMID:
27910301
12.

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.

Puymirat E, Riant E, Aissaoui N, Soria A, Ducrocq G, Coste P, Cottin Y, Aupetit JF, Bonnefoy E, Blanchard D, Cattan S, Steg G, Schiele F, Ferrières J, Juillière Y, Simon T, Danchin N.

BMJ. 2016 Sep 20;354:i4801. doi: 10.1136/bmj.i4801. Erratum in: BMJ. 2016 Oct 17;355:i5602.

13.

Isolated septal myocardial infarction due to spontaneous coronary artery dissection.

Chasseriaud W, Tearney GJ, Montaudon M, Fialon B, Coste P, Gerbaud E.

Int J Cardiol. 2016 Jun 1;212:259-61. doi: 10.1016/j.ijcard.2016.03.123. Epub 2016 Mar 24. No abstract available.

PMID:
27057931
14.

[Characteristics and management of ST-elevation myocardial infarction in France: Regional variations in 2010].

Sokoloff A, Lefèvre G, Teixeira N, Puymirat E, Beygui F, Vanzetto G, Richard P, Khalife K, Blanchard D, Gilard M, Coste P, Farah B, Elbaz M, Leclercq F, Ferrari E, Bonnet JL, Meyer P, Belle L, Funck F, Motreff P, Virot P, Geugniaud PY, Ferrières J, Simon T, Danchin N.

Ann Cardiol Angeiol (Paris). 2015 Dec;64(6):427-33. doi: 10.1016/j.ancard.2015.10.001. Epub 2015 Nov 5. French.

PMID:
26547524
15.

Factors Associated With Infarct-Related Artery Patency Before Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (from the FAST-MI 2010 Registry).

Bailleul C, Puymirat E, Aissaoui N, Schiele F, Ducrocq G, Coste P, Blanchard D, Brasselet C, Elbaz M, Steg PG, Le Breton H, Bonnefoy-Cudraz E, Montalescot G, Cottin Y, Goldstein P, Ferrières J, Simon T, Danchin N; FAST-MI Investigators.

Am J Cardiol. 2016 Jan 1;117(1):17-21. doi: 10.1016/j.amjcard.2015.09.043. Epub 2015 Oct 23.

PMID:
26541905
16.

Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry.

Puymirat E, Caudron J, Steg PG, Lemesle G, Cottin Y, Coste P, Schiele F, de Labriolle A, Bataille V, Ferrières J, Simon T, Danchin N; FAST-MI investigators.

Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):26-33. doi: 10.1177/2048872615610893. Epub 2016 Sep 20.

PMID:
26450784
17.

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Guérin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Claeys MJ, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, De Poli F, Morice MC, Ider O, Dubois-Randé JL, Unterseeh T, Le Breton H, Béard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Elmer E, Hansson MJ, Bergerot C, Boussaha I, Jossan C, Derumeaux G, Mewton N, Ovize M.

N Engl J Med. 2015 Sep 10;373(11):1021-31. doi: 10.1056/NEJMoa1505489. Epub 2015 Aug 30.

18.

ST-segment resolution with bivalirudin versus heparin and routine glycoprotein IIb/IIIa inhibitors started in the ambulance in ST-segment elevation myocardial infarction patients transported for primary percutaneous coronary intervention: The EUROMAX ST-segment resolution substudy.

Van't Hof A, Giannini F, Ten Berg J, Tolsma R, Clemmensen P, Bernstein D, Coste P, Goldstein P, Zeymer U, Hamm C, Deliargyris E, Steg PG.

Eur Heart J Acute Cardiovasc Care. 2017 Aug;6(5):404-411. doi: 10.1177/2048872615598633. Epub 2015 Aug 6.

PMID:
26250825
19.

Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients.

Schaaf MJ, Mewton N, Rioufol G, Angoulvant D, Cayla G, Delarche N, Jouve B, Guerin P, Vanzetto G, Coste P, Morel O, Roubille F, Elbaz M, Roth O, Prunier F, Cung TT, Piot C, Sanchez I, Bonnefoy-Cudraz E, Revel D, Giraud C, Croisille P, Ovize M.

J Cardiol. 2016 Mar;67(3):248-53. doi: 10.1016/j.jjcc.2015.05.008.

20.

Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial.

Hamon M, Coste P, Van't Hof A, Ten Berg J, Clemmensen P, Tabone X, Benamer H, Kristensen SD, Cavallini C, Marzocchi A, Hamm C, Kanic V, Bernstein D, Anthopoulos P, Deliargyris EN, Steg PG.

Circ Cardiovasc Interv. 2015 Jun;8(6):e002049. doi: 10.1161/CIRCINTERVENTIONS.114.002049.

PMID:
26056249
21.

Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).

Mewton N, Cung TT, Morel O, Cayla G, Bonnefoy-Cudraz E, Rioufol G, Angoulvant D, Guerin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, Morice MC, Monassier JP, Ider O, Dubois-Randé JL, Unterseeh T, Lebreton H, Beard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Hansson MJ, Elmer E, Boussaha I, Jossan C, Torner A, Claeys M, Garcia-Dorado D, Ovize M; CIRCUS Study Investigators.

Am Heart J. 2015 Jun;169(6):758-766.e6. doi: 10.1016/j.ahj.2015.02.020. Epub 2015 Mar 13.

22.

Diuretic versus placebo in normotensive acute pulmonary embolism with right ventricular enlargement and injury: a double-blind randomised placebo controlled study. Protocol of the DiPER study.

Gallet R, Meyer G, Ternacle J, Biendel C, Brunet A, Meneveau N, Rosario R, Couturaud F, Sebbane M, Lamblin N, Bouvaist H, Coste P, Maitre B, Bastuji-Garin S, Dubois-Rande JL, Lim P.

BMJ Open. 2015 May 22;5(5):e007466. doi: 10.1136/bmjopen-2014-007466.

23.

Percutaneous mitral commissurotomy during pregnancy: With or without pelvic lead apron use?

Leroux L, Peragallo N, Dijos M, Murman M, Casassus F, Coste P, Dos Santos P.

Int J Cardiol. 2015 Jun 1;188:70-2. doi: 10.1016/j.ijcard.2015.04.058. Epub 2015 Apr 9. Review. No abstract available.

PMID:
25885755
24.

The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.

Casassus F, Corre J, Leroux L, Chevalereau P, Fresselinat A, Seguy B, Calderon J, Coste P, Ouattara A, Roques X, Barandon L.

J Interv Cardiol. 2015 Feb;28(1):41-50. doi: 10.1111/joic.12172.

PMID:
25689547
25.

Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography).

Clemmensen P, Wiberg S, Van't Hof A, Deliargyris EN, Coste P, Ten Berg J, Cavallini C, Hamon M, Dudek D, Zeymer U, Tabone X, Kristensen SD, Bernstein D, Anthopoulos P, Prats J, Steg PG.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):214-220. doi: 10.1016/j.jcin.2014.11.002.

26.

Impact of fondaparinux versus enoxaparin on in-hospital bleeding and 1-year death in non-ST-segment elevation myocardial infarction. FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) 2010.

Puymirat E, Schiele F, Ennezat PV, Coste P, Collet JP, Bonnefoy-Cudraz E, Roul G, Richard P, Simon T, Danchin N.

Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):211-9. doi: 10.1177/2048872614544857. Epub 2014 Jul 29.

PMID:
25075006
27.

Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial.

Zeymer U, van 't Hof A, Adgey J, Nibbe L, Clemmensen P, Cavallini C, ten Berg J, Coste P, Huber K, Deliargyris EN, Day J, Bernstein D, Goldstein P, Hamm C, Steg PG.

Eur Heart J. 2014 Sep 21;35(36):2460-7. doi: 10.1093/eurheartj/ehu214. Epub 2014 May 21.

28.

Peri-infarct ischaemia assessed by cardiovascular MRI: comparison with quantitative perfusion single photon emission CT imaging.

Gerbaud E, Cochet H, Bullier E, Ragot C, Gilbert SH, Douard H, Pucheu Y, Laurent F, Coste P, Bordenave L, Montaudon M.

Br J Radiol. 2014 Jul;87(1039):20130774. doi: 10.1259/bjr.20130774. Epub 2014 Apr 29.

29.

Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort.

Danchin N, Puymirat E, Steg PG, Goldstein P, Schiele F, Belle L, Cottin Y, Fajadet J, Khalife K, Coste P, Ferrières J, Simon T; FAST-MI 2005 Investigators.

Circulation. 2014 Apr 22;129(16):1629-36. doi: 10.1161/CIRCULATIONAHA.113.005874. Epub 2014 Mar 21.

PMID:
24657993
30.

Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score.

Fox KA, Fitzgerald G, Puymirat E, Huang W, Carruthers K, Simon T, Coste P, Monsegu J, Gabriel Steg P, Danchin N, Anderson F.

BMJ Open. 2014 Feb 21;4(2):e004425. doi: 10.1136/bmjopen-2013-004425.

31.

[Intermediate term outcome in 70 patients with Tako-Tsubo syndromes].

Réglat C, Chevalier JM, Coste P, Godon P, Renault L, Roudaut R, Seguy B, Gerbaud E.

Ann Cardiol Angeiol (Paris). 2014 Apr;63(2):75-82. doi: 10.1016/j.ancard.2014.01.008. Epub 2014 Jan 16. French.

PMID:
24485824
32.

Prevalence, clinical profile and 3-year survival of acute myocardial infarction patients with and without obstructive coronary lesions: the FAST-MI 2005 registry.

André R, Elbaz M, Simon T, Khalife K, Lim P, Ennezat PV, Coste P, Le Breton H, Bataille V, Ferrières J, Danchin N.

Int J Cardiol. 2014;172(1):e247-9. doi: 10.1016/j.ijcard.2013.12.103. Epub 2014 Jan 4. No abstract available.

PMID:
24447751
33.

Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.

Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P.

Arch Cardiovasc Dis. 2014 Jan;107(1):33-41. doi: 10.1016/j.acvd.2013.12.001. Epub 2014 Jan 14.

34.

Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention.

Steg PG, van 't Hof A, Clemmensen P, Lapostolle F, Dudek D, Hamon M, Cavallini C, Gordini G, Huber K, Coste P, Thicoipe M, Nibbe L, Steinmetz J, Ten Berg J, Eggink GJ, Zeymer U, Campo dell' Orto M, Kanic V, Deliargyris EN, Day J, Schuette D, Hamm CW, Goldstein P.

Am Heart J. 2013 Dec;166(6):960-967.e6. doi: 10.1016/j.ahj.2013.08.025. Epub 2013 Nov 7.

PMID:
24268209
35.

Bivalirudin started during emergency transport for primary PCI.

Steg PG, van 't Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Campo dell' Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P; EUROMAX Investigators.

N Engl J Med. 2013 Dec 5;369(23):2207-17. doi: 10.1056/NEJMoa1311096. Epub 2013 Oct 30.

36.

A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).

Collet JP, Huber K, Cohen M, Zeymer U, Goldstein P, Pollack C Jr, Silvain J, Henry P, Varenne O, Carrié D, Coste P, Angioi M, Le Breton H, Cayla G, Elhadad S, Teiger E, Filippi E, Aout M, Vicaut E, Montalescot G; ATOLL Investigators.

Am J Cardiol. 2013 Nov 1;112(9):1367-72. doi: 10.1016/j.amjcard.2013.07.003. Epub 2013 Sep 5.

PMID:
24012033
37.

[Caseous calcification of the mitral annulus, variable and revealing clinical picture, and the contribution of cardiac tomodensitometry to the diagnosis: report of two cases].

Cetran L, Corneloup O, Dijos M, Montaudon M, Roudaut R, Coste P, Laurent F, Gerbaud E.

Ann Cardiol Angeiol (Paris). 2014 Apr;63(2):114-8. doi: 10.1016/j.ancard.2013.03.008. Epub 2013 Apr 10. French.

PMID:
23806861
38.

Estimation of pulmonary pressures and diagnosis of pulmonary hypertension by Doppler echocardiography: a retrospective comparison of routine echocardiography and invasive hemodynamics.

Lafitte S, Pillois X, Reant P, Picard F, Arsac F, Dijos M, Coste P, Dos Santos P, Roudaut R.

J Am Soc Echocardiogr. 2013 May;26(5):457-63. doi: 10.1016/j.echo.2013.02.002. Epub 2013 Mar 16.

PMID:
23510536
39.

Absolute quantification of left ventricular global and regional function at nuclear MPI using ultrafast CZT SPECT: initial validation versus cardiac MR.

Cochet H, Bullier E, Gerbaud E, Durieux M, Godbert Y, Lederlin M, Coste P, Barat JL, Laurent F, Montaudon M.

J Nucl Med. 2013 Apr;54(4):556-63. doi: 10.2967/jnumed.112.110577. Epub 2013 Feb 5.

40.

Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study.

Maheu E, Cadet C, Marty M, Moyse D, Kerloch I, Coste P, Dougados M, Mazières B, Spector TD, Halhol H, Grouin JM, Lequesne M.

Ann Rheum Dis. 2014 Feb;73(2):376-84. doi: 10.1136/annrheumdis-2012-202485. Epub 2013 Jan 23.

41.

Caseous necrosis of mitral annulus: a rare cause of stroke.

Corre J, Leroux L, Coste P.

Case Rep Cardiol. 2013;2013:748241. doi: 10.1155/2013/748241. Epub 2013 May 12.

42.

Abciximab for distal thromboaspiration catheter-related embolization in ST-segment elevated myocardial infarction.

Gerbaud E, Seguy B, Coste P.

Arch Cardiovasc Dis. 2012 Nov;105(11):616-8. doi: 10.1016/j.acvd.2011.07.006. Epub 2012 Jan 14. No abstract available.

43.

What next after failed septal ventricular tachycardia ablation?

Roten L, Derval N, Pascale P, Jais P, Coste P, Sacher F.

Indian Pacing Electrophysiol J. 2012 Jul;12(4):180-5. Epub 2012 Jul 28.

44.

Determination of central blood pressure by a noninvasive method (brachial BP and QKD interval).

Cremer A, Butlin M, Codjo L, Coulon P, Ranouil X, Joret C, Coste P, Asmar R, Avolio A, Gosse P.

J Hypertens. 2012 Aug;30(8):1533-9. doi: 10.1097/HJH.0b013e328354dd26.

PMID:
22688261
45.

Echocardiographic evaluation and N-terminal pro-brain natriuretic peptide measurement of patients hospitalized for heart failure during weaning from mechanical ventilation.

Gerbaud E, Erickson M, Grenouillet-Delacre M, Beauvieux MC, Coste P, Durrieu-Jaïs C, Hilbert G, Castaing Y, Vargas F.

Minerva Anestesiol. 2012 Apr;78(4):415-25. Epub 2012 Feb 6.

46.

OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group.

Gossec L, Paternotte S, Bingham CO 3rd, Clegg DO, Coste P, Conaghan PG, Davis AM, Giacovelli G, Gunther KP, Hawker G, Hochberg MC, Jordan JM, Katz JN, Kloppenburg M, Lanzarotti A, Lim K, Lohmander LS, Mahomed NN, Maillefert JF, Manno RL, March LM, Mazzuca SA, Pavelka K, Punzi L, Roos EM, Rovati LC, Shi H, Singh JA, Suarez-Almazor ME, Tajana-Messi E, Dougados M; OARSI-OMERACT Task Force Total Articular Replacement as Outcome Measure in OA.

J Rheumatol. 2011 Aug;38(8):1765-9. doi: 10.3899/jrheum.110403.

47.

Comparison of efficacy and safety of a standard versus a loading dose of clopidogrel for acute myocardial infarction in patients ≥ 75 years of age (from the FAST-MI registry).

Puymirat E, Aïssaoui N, Coste P, Dentan G, Bataille V, Drouet E, Mulak G, Carrié D, Blanchard D, Simon T, Danchin N.

Am J Cardiol. 2011 Sep 15;108(6):755-9. doi: 10.1016/j.amjcard.2011.04.028. Epub 2011 Jul 2.

PMID:
21726837
48.

Virus-negative active lymphocytic myocarditis progressing to a fibrotic stage.

Gerbaud E, Vital A, Erickson M, Montaudon M, Harcaut E, Pellegrin JL, Laurent F, Coste P.

Case Rep Med. 2011;2011:740928. doi: 10.1155/2011/740928. Epub 2011 Mar 16.

49.

Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries.

Gerbaud E, Harcaut E, Coste P, Erickson M, Lederlin M, Labèque JN, Perron JM, Cochet H, Dos Santos P, Durrieu-Jaïs C, Laurent F, Montaudon M.

Int J Cardiovasc Imaging. 2012 Apr;28(4):783-94. doi: 10.1007/s10554-011-9879-1. Epub 2011 May 3.

PMID:
21538065
50.

Early detection of myocardial stunning using low-dose dobutamine magnetic resonance imaging.

Gerbaud E, Montaudon M, Coste P.

Arch Cardiovasc Dis. 2011 Feb;104(2):134-7. doi: 10.1016/j.acvd.2010.03.013. Epub 2010 Aug 26. No abstract available.

Supplemental Content

Support Center